Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

610 ARTÍCULOS , VIENDO DEL 76 AL 90

Amyloid-Related Imaging Abnormalities Summit Special Proceedings: Cardiovascular and Stroke Considerations for β-Amyloid Immunotherapy in Alzheimer Disease

Greenberg SM, Iadecola C, Chou SH, Cogswell PM, Elkind MSV, Hicks WJ, Le C, Levine DA, Lipton R, Massimo L, Mohl SM, Seshadri S, Snyder HM, Yaffe K, Zachrison KS; ARIA Summit Working Group.

J Am Heart Assoc. 2026 Sep;15(17):e048108. doi: 10.1161/JAHA.125.048108. Epub 2026 Aug 20.

Dementia Risk After Glaucoma Surgery and Medical Therapy: A Multicentre Real-World Cohort Study

Lin LY, Wu JS, Jeng WJ, Tsai CH, Liu SY, Huang TW, Yuliani FS, Lin SH.

Int J Geriatr Psychiatry. 2026 Sep;41(9):e70252. doi: 10.1002/gps.70252.

Auvelity (Dextromethorphan-Bupropion) for Agitation and Aggression in Alzheimer's Disease Dementia: Mechanism, Efficacy, Safety, and Clinical Considerations

Sarangal M, Sarangal C, Vora J, Soni K.

Psychopharmacol Bull. 2026 Sep 18;56(4 Suppl 1):82-87. doi: 10.64719/pb.20773.

Eye-tracking-based tablet application for enhanced cognitive assessment: a clinical trial for software as a medical device (SaMD)

Takami Y, Miki T, Takeya Y, Rakugi H, Morishita R, Takeda S.

Geroscience. 2026 Aug;48(4):5379-5391. doi: 10.1007/s11357-025-01941-x. Epub 2025 Oct 20.

Neurovascular unit dysfunction in vascular cognitive impairment: Mechanisms, biomarkers, and translational strategies

Hoyer-Kimura C, Hay M.

Exp Neurol. 2026 Sep;403:115815. doi: 10.1016/j.expneurol.2026.115815. Epub 2026 May 7.

External validation of dementia risk models in a United Kingdom population-based prospective cohort among stroke survivors

Brain J, Jack RH, Maree Stephan BC, Hing Tang EY.

J Clin Epidemiol. 2026 Sep;197:112339. doi: 10.1016/j.jclinepi.2026.112339. Epub 2026 May 21.

Comparative dementia risk associated with SGLT2 inhibitors versus DPP-4 inhibitors in patients with type 2 diabetes following traumatic brain injury: A propensity score-matched Cohort study

Kuo YD, Hung SJ, Kuo CY, Lai CC, Kuo JR.

Diabetes Res Clin Pract. 2026 Sep;239:113445. doi: 10.1016/j.diabres.2026.113445. Epub 2026 Jul 16.

Evaluation of the Addenbrooke's Cognitive Examination-Revised in a routine cognitive outpatient clinic

Novotný JS, Thatcher A, Shatti D, Mofardin S, Rakuša M, Kolenc M, Zupan M, Frol S, Popović KŠ, Oblak JP, Bossert I, Kuruvilla T, Lyburn I, Trifiro G, Stokin GB.

J Alzheimers Dis. 2026 Sep;113(2):822-834. doi: 10.1177/13872877261471428. Epub 2026 Jul 30.

Bacopa monnieri and Alzheimer's disease: mechanistic convergence, cognitive outcomes and translational perspectives

Kumawat A, Sharma MM, Nathani S.

Inflammopharmacology. 2026 Sep;34(9):6035-6057. doi: 10.1007/s10787-026-02369-1. Epub 2026 Aug 19.

Lesion-Level Subtypes of White Matter Hyperintensity Evolution Beyond Spatial Location

Gonzalez-Gomez R, Tagliazuchi E, Campo CG, Medel V, Bennett DA, Iturria-Medina Y.

Neurology. 2026 Sep 22;107(6):e218472. doi: 10.1212/WNL.0000000000218472. Epub 2026 Aug 27.

Correlation between MMP-3-1171 5A/6A polymorphism and the risk of Alzheimer's disease: A meta-analysis

Wang Y, Zhu S, Ma Y, Chen X, Zhou M.

Medicine (Baltimore). 2026 Sep 11;105(37):e50560. doi: 10.1097/MD.0000000000050560.

CSF Tau and Amyloid Biomarkers in Cognitive Impairment Across the ALS-FTD Spectrum: A Systematic Narrative Review and Evidence Map

Ali A, Arif M, Ashraf U, Elahi S, Mustafa A, Yasir MB, Sarfraz W, Ansari AU, Masood HMY, Shabbir MA, Abdullah A, Sharma MK.

Brain Behav. 2026 Sep;16(9):e71740. doi: 10.1002/brb3.71740.

Platelet count polygenic scores may modify the effect of aspirin in primary prevention of dementia

Fransquet PD, Yu C, Tran C, Hussain SM, Brodtmann A, Tonkin AM, Nelson MR, Ryan J, McNeil JJ, Lacaze P.

Alzheimers Dement. 2026 Sep;22(9):e71817. doi: 10.1002/alz.71817.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias